From The Journal news
Australia’s Drugs Watchdog has today announced that psychedelic substances MDMA and psilocybin – more commonly known as ecstasy and magic mushrooms – will soon be used in the treatment of depression and post-traumatic stress.
Psychiatrists will be able to prescribe the two substances from July, the Therapeutic Goods Administration said after finding “sufficient evidence for potential benefits in certain patients”.
The two drugs are currently “prohibited substances” and can only be used in closely controlled clinical trials.
The administration said they had been found to be “relatively safe” when administered in a medical setting and provided an “altered state of consciousness” that could help patients.
To read the full article, follow this link>>>.